2m 2m 2m 2m 2m 2m 2m
Nuo Therapeutics (AURX)
OTC
$1.06-$0.01 (-0.93%)
Price as of Jun 03, 2026- $47.9MMarket Cap
- -37.65%1-Year Change
- BiotechnologyIndustry
Nuo Therapeutics (AURX)
$1.06-$0.01 (-0.93%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.1M +126.24% | 1.4M +124.34% | 608,525 +442.12% | 112,250 N/A | |
Cost of Revenue | 1.1M +261.76% | 302,842 +140.18% | 126,092 +556.25% | 19,214 N/A | |
Gross Profit | 2.2M +108.78% | 1.1M +120.20% | 482,433 +418.54% | 93,036 N/A | |
Sales and Marketing Expense | 4.7M +34.50% | 3.5M -3.58% | 3.7M +6.95% | 3.4M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 85,463 +271.22% | 23,022 +50.21% | 15,327 +124.51% | 6,827 N/A | |
Total Operating Expenses | 4.7M +34.50% | 3.5M -3.58% | 3.7M +6.95% | 3.4M +3,664.89% | |
Operating Profit | -2.5M +2.39% | -2.5M -22.42% | -3.2M -4.59% | -3.3M +3,562.29% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -804 N/A | N/A N/A | -3,162 +50.36% | -2,103 N/A | |
Interest Income and Expense and Net | -804 N/A | 0 +100.00% | -3,162 +50.36% | -2,103 N/A | |
Total Nonoperating Income and Expense | 5,237 +1,202.74% | 402 N/A | 0 -100.00% | 4,523 N/A | |
Income before Taxes | -2.5M +8.11% | -2.3M -26.73% | -3.2M -0.009% | -3.2M +3,398.11% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Net Income | -2.5M +8.11% | -2.3M -26.73% | -3.2M -0.009% | -3.2M +3,398.11% | |
Net Income from Continuing Operations Applicable to Common | -2.5M +8.11% | -2.3M -26.73% | -3.2M -0.009% | -3.2M +3,398.11% | |
Basic EPS and Net Income | -0.05 0.00% | -0.05 -37.50% | -0.08 0.00% | -0.08 +166.67% | |
Diluted EPS and Net Income | -0.05 0.00% | -0.05 -37.50% | -0.08 0.00% | -0.08 +166.67% | |
Basic Weighted Average Shares | 47.3M +4.16% | 45.4M +7.95% | 42.1M +5.19% | 40.0M +32.03% | |
Diluted Weighted Average Shares | 47.3M +4.16% | 45.4M +7.95% | 42.1M +5.19% | 40.0M +32.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 548,946 +93.49% | 283,714 -69.45% | 928,681 -54.73% | 2.1M +45.01% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 548,946 +93.49% | 283,714 -69.45% | 928,681 -54.73% | 2.1M +45.01% | |
Total Current Assets | 1.4M +63.97% | 841,546 -46.17% | 1.6M -40.66% | 2.6M +79.74% | |
Accumulated Depreciation | 518,304 +19.74% | 432,841 +5.62% | 409,819 +3.89% | 394,492 N/A | |
Property and Plant and Equipment and Net | 366,315 +106.93% | 177,022 +292.67% | 45,082 -15.20% | 53,165 N/A | |
Total Long-Term Assets | 366,315 +106.93% | 177,022 +292.67% | 45,082 -15.20% | 53,165 N/A | |
Total Assets | 1.8M +55.16% | 1.2M -36.66% | 1.9M -38.38% | 3.0M +107.88% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 1.3M +125.82% | 578,451 -14.24% | 674,527 +12.34% | 600,431 -10.79% | |
Total Long-Term Debt | 1.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 995,936 +923.10% | 97,345 -40.72% | 164,205 -35.76% | 255,592 N/A | |
Total Liabilities | 2.8M +314.65% | 675,796 -19.43% | 838,732 -2.02% | 856,022 +27.18% | |
Retained Earnings | -34.8M +7.79% | -32.3M +7.76% | -29.9M +11.85% | -26.8M +13.44% | |
Total Stockholders Equity | -956,559 -286.21% | 513,712 -50.56% | 1.0M -52.58% | 2.2M +176.39% | |
Total Shares Outstanding | 48.2M +2.91% | 46.8M +5.82% | 44.2M +5.84% | 41.8M +12.59% | |
Cash Flow | |||||
Cash from Operating Activities | -864,971 -61.24% | -2.2M -29.55% | -3.2M -14.53% | -3.7M +2,989.60% | |
Capital Expenditures | 274,756 +77.31% | 154,962 +2,039.18% | 7,244 -87.93% | 59,992 N/A | |
Cash from Investing Activities | -274,756 +77.31% | -154,962 +2,039.18% | -7,244 -87.93% | -59,992 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.4M -19.33% | 1.7M -12.81% | 2.0M +6.64% | 1.9M 0.00% | |
Financials Ratio | |||||
Gross Margin | 64.53% -17.08% | 77.82% -1.84% | 79.28% -4.35% | 82.88% N/A | |
Operating Margin | -81.48% -54.74% | -180.04% -65.42% | -520.65% -82.40% | -2,958.21% N/A | |
Return on Assets | -165.54% +9.26% | -151.51% +17.65% | -128.78% -8.37% | -140.55% N/A | |
Return on Equity | 1,134.58% +479.10% | -299.28% +52.43% | -196.34% -7.63% | -212.57% N/A | |
Revenue Growth | 126.24% +1.52% | 124.34% -71.88% | 442.12% N/A | N/A N/A | |
Current Ratio | 1.06 -27.39% | 1.45 -37.23% | 2.32 -47.18% | 4.39 N/A | |
Cash Ratio | 0.42 -14.33% | 0.49 -64.37% | 1.38 -59.70% | 3.42 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow